throbber
.. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
`.c - -
`.
`March 1997
`
`ISSN 0141-0768
`
`Volume 90
`
`Number 3
`
`Editorials
`Hazards of growing up
`Growth hormone for adults
`Issue of the day
`Are you competent with congenital heart disease?
`Original articles
`Death in heart disease
`Intestinal stenting to prevent adhesional obstruction
`Cardiac investigations before renal transplantation
`Review articles
`Why has stroke mortality been falling?
`Rosacea
`Economics of laboratory testing
`Case reports
`Eye drops and lethargy
`Long-term hypercalcaemia in sarcoidosis
`Lump in the groin--orthopaedic
`Kasabach-Merritt and Down's
`Enterocutaneous fistula in an Ethiopian
`Misleading presentation
`Chilblains .or cancer
`History:
`The missing doctor
`Per~onal papers
`Airships, space shuttles, and biologicals
`The treasures of Blythe House
`Art in hospitals
`The Gabo Fountain at St Thomas'
`Book · of the month
`Evolutionary psychiatry
`Letters
`Complementary medicine in the curriculum • useful plants •
`Community hospitals • Hospital-at-home • Save the ESR • Sailors,
`scurvy and science • Helicobacter pylori infection
`
`',
`Univ. ~; Minn
`Bio-Medical ·
`Librarv .
`97
`
`Published by The Royal Society of Medicine 1 Wimpole Street Lond
`
`Dr. Reddy's Laboratories, Ltd., et al.
`v.
`Galderma Laboratories, Inc.
`IPR2015-__
`Exhibit 1034
`
`The ROYAL
`SOCIETY lif
`MEDICINE
`
`. I
`
`I
`
`i
`
`I l_J
`
`.
`
`

`
`The ROYAL
`SOCIETY cif
`MEDICINE
`
`_ JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
`c__--
`
`March 1997
`
`Volume 90
`
`Number 3
`
`ISSN 0141-0768
`
`Editorials
`Hazards of growing up
`Growth hormone for adults
`
`lssue of the day
`Are you competent with congenital heart disease?
`
`Original articles
`Death in heart disease
`Intestinal stenting to prevent adhesional obstruction
`Cardiac investigations before renal transplantation
`Review articles
`Why has stroke mortality been falling?
`Rosacea
`Economics of laboratory testing
`Case reports
`Eye drops and lethargy
`Long-term hypercalcaemia in sarcoidosis
`Lump in the groin-orthopaedic
`Kasabach-Merritt and Down' s
`Enterocutaneous fistula in an Ethiopian
`Misleading presentation
`Chilblains or cancer
`History
`The missing doctor
`Personal papers
`Airships, space shuttles, and biologieals
`The treasures of Blythe House
`Art in hospitals
`The Gabo Fountain at St Thomas'
`
`Book of the month
`Evolutionary psychiatry
`letters
`Complementary medicine in the curriculum e useful plants e
`Community hospitals e Hospital-at-horne e Save the ESR e Sailors,
`scurvy and science e Helicobacter pylori infection
`
`Published by The Royal Society of Medicine 1 Wimpole Street London W1 M 8AE
`
`Exh. 1034
`
`

`
`JOURNAL OF THE ROYAL SOCIETY OF MEDICINE Volume 90 Marcll 1997
`
`Rosacea: classificatio and treatment
`Thomas Jansen MD Gerd Plewig MD
`
`J R Soc Med 1997;90:144-150
`
`Rosacea is a chronic skin disorder affecting the facial
`convexities, characterized by frequent flushing, persistent
`erythema, and telangiectases. During episodes of inflamma-
`tion additional features are swelling, papules and pustules.
`The disease was originally called acne rosacea, a misleading
`term that unfortunately persists 1•
`Rosacea is a common disease, especially in fair-skinned
`people of Celtic and northem European heritage; it has
`been called the curse of the Celts. It is rare in American and
`African blacks2. W omen are more often affected than men,
`but they seldom suffer the gross tissue and sebaceous gland
`hyperplasia of rhinophyma. Onset is usually between ages
`30 and 50. In a recent epidemiological study the prevalence
`was 10%, most of the patients having only a red face3. In
`young patients especially, there may be a history of acne and
`the conditions may coexist.
`
`PATHOGENESIS
`The exact aetiology of rosacea is unknown and theories
`abound4. Gastrointestinal disturbances, notably dyspepsia
`with gastric hypochlorhydria, were long suspected of being
`a causal factor, but controlled
`investigations with a
`gastrocamera5 and biopsy studies6 revealed no association.
`Helicobacter pylori has come under suspicion, but results are
`conflicting7 . For example, Powell et al. 8 found H. pylori
`antibody in 19 of 20 patients, while Schneider et al. 9 found
`no statistical difference in positivity between patients ( 49%)
`and controls
`( 43%). Psychogenic
`factors have been
`frequently implicated but there is no good evidence that
`the condition is associated with personality type or is
`precipitated by emotional disturbance.
`The theory of hypersensitivity to Demodex jolliculorum or
`its products is based primarily on the distribution of rosacea
`and the mite, the follicular nature of rosacea, and the
`finding of the mite in areas of acute inflammation in some
`cases of rosacea 10. However, D. jolliculorum mites are
`normal inhabitants of human follicles and sebaceous glands
`and application of 3% sulphur ointment, while resulting in
`clinical improvement of rosacea, did not affect the Demodex
`population11 . At most, the mite induces papule or pustule
`
`Department of Dermatology, Ludwig-Maximilians-University, Frauenlobstrasse
`9-11, D-80337 Munich, Germany
`Correspondence to: Thomas Jansen MD
`
`144
`
`in pre-existing rosacea. Rosacea was once
`formation
`regarded as a seborrhoeic disease. Seborrhoea is, however,
`not always present12 . Unlike acne vulgaris, rosacea is not
`primarily a disease of sebaceous follicles.
`The pathogenesis of rosacea thus remains obscure. What
`is certain, however, is that rosacea patients are constitu-
`tionally predisposed to blushing and flushing. The basic
`abnormality seems to be a microcirculatory disturbance of
`the function of the facial angular veins 13 . Statistical
`associations between rosacea-related flushing and migraine
`suggest a shared disorder of vascular regulation 14 but there
`is no direct evidence that rosacea is primarily a vascular
`disorder. The response of the facial vessels to adrenaline,
`histamine and acetylcholine is normal, 15 and the vessels do
`not seem abnormally fragile 16 so the main abnormality is
`probably in the dermis surrounding blood vessels rather
`than in vessel walls. In addition, the distribution of rosacea
`is not identical with the flush area. A very important
`background feature
`is sun damage. Rosacea is always
`associated with solar elastosis and often with helioderma-
`tosis 17 . Fair-skinned patients with rosacea type I will often
`give a history of sun sensitivity.
`
`CLINICAL FINDINGS
`Rosacea is usually symmetrically distributed over the face and
`is particularly obvious over the nose, cheeks, chin, forehead,
`and glabella. Occasionally, lesions are seen at extrafacial sites
`including the retroauricul~ areas, the V -shaped area of the
`ehest, the neck, the back, and the scalp and extremities 18 . The
`hallmarks of rosacea are papules and papulopustules, vivid-red
`erythema, and telangiectases and a history of flushing.
`Comedones are notably absent. In severe cases papules are
`numerous enough to be confluent. Granulomatous changes
`can develop in later stages, sometimes receiving special
`designations such as lupoid rosacea. Rhinophyma and other
`phymas are the ultimate tissue reactions. For didactic but also
`for therapeutic reasons rosacea is classified into stages and
`grades. The progression is not inevitable, and few patients
`experience the full course of the disease.
`
`Episodic erythema
`Most rosacea patients react with transient erythema on the
`central areas of the face, less often the neck and the V -shaped
`area of the ehest. These individuals are constitutionally
`
`Exh. 1034
`
`

`
`JOURNAL OF THE ROYAL SOCIETY OF MEDlCINE Volume 90 March 199
`
`predisposed to blushing and flushing (rosacea diathesis). The
`reactions are more frequent and more easily induced than
`ordinary blushing. Numerous non-specific stimuli such as
`ultraviolet radiation, heat, cold, chemical irritation, strong
`emotions, alcoholic beverages, hot drinks, and spicy food
`can trigger these flares. It is a mistaken belief that tea and
`coffee are precipitants; the specific stimulus is heat19 .
`Among the mediators proposed to be involved in the
`erythematous response are substance P, histamine, seroto-
`nin, and prostaglandins but the trigger remains unknown.
`
`Stage I
`The erythema persists for hours and days, hence the old
`description erythema congestivum. Erythema lasting only a
`few minutes is not early rosacea. Telangiectases become
`progressively more prominent, forming sprays on the nose,
`nasolabial
`folds, cheeks, and glabella. Most patients
`complain of sensitive skin that stings and burns after
`application of cosmetics, fragrances, and certain sunscreens.
`Trauma from abrasives and peeling agents readily induces
`long-lasting erythema. Thus the facial skin is unusually
`vulnerable to chemical and physical stimuli.
`
`Stage II
`Inflammatory papules and pustules develop and persist for
`weeks. Some papules show a small pustule at the top. The
`lesions are always follicular in origin-mainly sebaceous
`follicles but also the smaller and more numerous hair
`follicles. The deeper inflammatory lesions may heal with
`scarring, but scars are small and tend to be shallow. Facial
`pores become larger and more prominent. If there has been
`heavy solar exposure for decades, the stigmata of photo-
`darnage become superimposed-namely elastosis, solar
`comedones, and heliodermatosis. The papulopustular
`attacks become more frequent. Rosacea may extend over
`the entire face and even spread to the scalp, especially if the
`patient is balding. Itchy follicular pustules of the scalp are
`typical. Bacteriological studies of these pustules reveal
`nothing of interest. Finally the sides of the neck and the
`retroauricular and presternal area may be affected. Even the
`palms may show persistent erythema.
`
`Stage 111
`A small proportion of patients progress to the worst
`expressions of the disease-namely, large inflammatory
`nodules, furunculoid infiltrations, and tissue hyperplasia.
`These derangements occur particularly on the cheeks and
`nose, less often on the chin, forehead, or ears. The facial
`contours become coarse, thickened, and irregular. Finally
`the patient shows inflamed and thickened oedematous skin
`with large pores, resembling the surface of an orange (peau
`
`d' orange). These coarse features are due to inflammatory
`infiltratic>n, connective tissue hypertrophy with masses of
`collagen deposition, diffuse sebaceous gland hyperplasia,
`and overgrowth of individual sebaceous glands forming
`dozens of yellowish umbilicated papules on cheeks,
`forehead, temples and nose. Thickened folds and ridges
`create a grotesque appearance resembling the leonine fades
`of leprosy. The ultimate deformities are the phymas, of
`which rhinophyma is the archetype.
`
`ROSACEA VARIANTS
`The diagnosis of rosacea in its dassie forms presents no
`difficulty. The variants, however, may be overlooked or
`misdiagnosed.
`
`Persistent oedema of rosacea
`The published work hardly mentions this distressing variant.
`It has been reported as Morbihan disease or rosaceous
`lymphoedema20,21 . A hard non-pitting swelling is found on
`the areas involved, mainly on the forehead, glabella, nose,
`or cheeks. A similar oedema sometimes arises in acne andin
`the Melkersson-Rosenthal syndrome; it develops against a
`background of chronic inflammation of any cause, including
`bacterial infection.
`
`Ophthalmie rosacea
`Eye involvement is surprisingly common. Indeed, the disease
`may begin in the eye and escape diagnosis for a long time. The
`ophthalmic signs include blepharitis, conjunctivitis, iritis,
`iridocyclitis, hypopyon-iritis, and even' k~ratitis22 . The term
`ophthalmic rosacea covers all these signs. The incidence is not
`known but more than half of patients participating in a
`cooperative isotretinoin trial for the treatment of rosacea
`were diagnosed by ophthalmologists as having inflammatory
`eye involvement23 , blepharitis and conjunctivitis being the
`most common. The ophthalmic complications are indepen-
`dent of the severity of the facial rosacea but there is a strong
`correlation between the degree of eye involvement and a
`tendency to flushing24• Rosacea keratitis has an unfavourable
`prognosis, and in extreme cases leads to corneal opacity and
`blindness. Perhaps the most frequent" eye sign is chronically
`inflamed margins of the eyelids, with scales and crusts, quite
`similar to seborrhoeic dermatitis, with which it is often
`confused. Pain and photophobia may be present. All patients
`with progressive rosacea should be seen by an ophthalmologist.
`
`Lupoid or granulomatous rosacea
`Some patients develop epithelioid (lupoid) granulomas in a
`diffuse pattern25 . Clinically, dozens ofbrown-red papules or
`little nodules on a diffuse erythema, frequently involving the
`lower eyelids, are seen. Histopathological examination
`
`145
`
`Exh. 1034
`
`

`
`JOURNAL OF THE ROYAL SOCIETY OF MEDICINE Volurne 90 March 1997
`
`shows perifollicular and perivascular granulomas. The
`concept of a rosacea-like tuberculide of Lewandowsky was
`based only on the tuberculoid structure found histologically
`in many papules; however,
`the condition is probably
`unrelated
`to
`tuberculosis.
`Its course
`is chronic and
`unremittent. Differential diagnosis includes lupoid perioral
`dermatitis,
`lupoid steroid rosacea, and micronodular
`sarcoidosis.
`
`Steroid rosacea
`When a rosacea patient is erroneously treated with topical
`the disorder may at first respond, but the
`steroids
`improvement will be followed by steroid atrophy with
`thinning of the skin and an increase in telangiectases26 . The
`complexion becomes dark-red with a copper-like tone.
`Soon the surface becomes studded with follicular, round,
`deep papulopustules and firm nodules. The appearance is
`shocking, with a flaming red, scaling, papule-covered face.
`The distribution can extend over the entire area of
`application of the topical steroid, often up to the hairline.
`Steroid rosacea is a pitiable, avoidable condition which in
`addition
`to disfigurerneut
`is accompanied by severe
`discomfort and pain. Withdrawal of the steroid is followed
`by exacerbation of the disease.
`
`Gram-negative rosacea
`This is a newcomer among Gram-negative infections27.
`Clinically it looks like stage II or III disease. Multiple tiny
`yellow pustules (type I) or deep-seated nodules (type II)
`increase suspicion. Neither oral antibiotics nor metronida-
`zole will control it. The diagnosis rests on demonstration of
`Gram-negative organisms by culturing the contents of
`several pustules. The disease is analogaus to Gram-negative
`folliculitis which sometimes develops on top of acne
`vulgaris28 . The organisms· are the , same: Klebsiella, Proteus,
`Escherichia coli, Pseudomonas, Acinetobacter, and others.
`
`Rosacea conglobata
`Rarely a patient with severe rosacea shows a reaction that
`mirnies acne conglobata, with haemorrhagic nodular
`abscesses and indurated plaques. The course is progressive
`and chronic. This variant mainly occurs in women. It may
`be provoked by oral
`ingestion of halogen-containing
`preparations. Diagnostic features are pre-existing rosacea
`and Iimitation to the face, with no other signs of acne
`conglobata on back, ehest, shoulders, or extremities.
`
`Rosacea fulminans
`This variant was first described by O'Leary and Kierland29
`under the designation pyoderma faciale. It has been a matter
`of controversy ever since. One can say with certainty that it
`is not a variant of acne; neither is it pyoderma. The name
`
`rosacea fulminans was coined by analogy with its acne
`counterpart, acne fulminans 30,31 . This is a conglobate,
`nodular disease springing up abruptly on the face of young
`females. Curiously, it does not occur in males. Rosacea
`fulminans is confined to the face. Once seen it is never
`forgotten. Monstrous coalescent nodules and confluent
`draining sinuses occupy most of the face. The main
`locations are the chin, cheeks, and forehead. Ripe abscesses
`top of the
`form with multiple pustules riding on
`is diffusely reddened.
`carbunculoid nodules. The face
`Seborrhoea is a constant feature but may be overlooked.
`When questioned closely, patients will often describe the ·
`development of oiliness before the onset. Previous acne or
`rosacea
`is usually denied; however, we perceived a
`connection to rosacea because, after the stormy blow-up,
`their appearance. Some
`signs of rosacea often make
`patients, too, have been flushers and blushers. Aetiology
`remains obscure. Often blamed is severe emotional stress,
`such as the death of a family member, divorce, or loss of a
`lover, but some patients are stress-free. The prognosis is
`excellent. Once the disease has been brought under control
`it does not recur. Differential diagnosis includes acne
`conglobata (young patients, mostly males, Ionger history,
`other signs of acne, comedones, scars, seborrhoea, no
`flushing or blushing), acne fulminans (usually seen in
`teenage boys), bromoderma, iododerma, and virilizing tumours.
`
`PHYMAS IN ROSACEA
`Phyma is the Greek word for swelling, mass, or bulb.
`Phymas occur in various -;zreas of thtt face and ears,
`rhinophyma (rhinos=nose) heilig the commonest. It occurs
`exclusively in men and fortunately it is a rare complication.
`Rhinophyma may be perceived by the public as due to
`excessive alcohol consumption, as in the comedian W C
`Fields. The bulbous nose develops over many years as a
`increase
`in connective
`tissue,
`result of progressive
`sebaceous gland hyperplasia, ectatic veins, and chronic
`deep inflammation. Rhinophyma may accompany stage III
`rosacea but in some patients the signs of rosacea in the rest
`of the face are surprisingly mild. Four variants of
`rhinophyma can be recognized. In the glandular form, the
`nose is enlarged mainly because of enormous lobular
`sebaceous gland hyperplasia. The surface is pitted, with
`deeply indented and mildly distorted follicular orifices. The
`tumorous expansions of the nose are often asymmetrical
`and of varying size. Humps and sulci occur. Sebum
`excretion is increased. Compression by the fingers yields a
`white pasty substance consisting of an amalgam of
`corneocytes, sebum, bacteria, and sometimes Demodex
`mites. In the fibrous form, diffuse hyperplasia of the
`connective tissue dominates the picture32 . The amount of
`sebaceous hyperplasia is variable. In the fibroangiomatous
`
`146
`
`Exh. 1034
`
`

`
`JOURNAL OF THE ROYAL SOCIETY OF MEDICINE Vo!ume 90 March 199
`
`form, the nose is copper-red to dark red, greatly enlarged,
`oedematous, and covered by a network of large ectatic
`veins. Pustules are frequently present. The actinic form is
`characterized by nodular masses of elastic tissue distorting
`the nose. These are similar to the elastomas that occur in
`older individuals with over-exposure to sunlight. This
`variety is mainly observed in people of Celtic origin.
`Phymas occur in other locations such as chin, forehead,
`eyelids and ears33,34.
`
`HISTOPATHOLOGY
`Histopathology of rosacea varies with the stage and type of
`disease35 . The changes often resemble those of other
`chronic disorders. Skin darnage by surrlight is a common
`background feature, so severe elastosis is often present. In
`stage I rosacea there are ectatic venules and lymphatics,
`slight oedema, and sparse lymphatic perivascular infiltra-
`tion. Moderate hyperplasia of the elastic tissue is present
`with increased curled, thickened elastic fibres ( elastolysis).
`In stage II there is increasing lymphohistiocytic perivascular
`and perifollicular infiltration. Intrafollicular collections of
`neutrophils are often found, and are always present when
`pustules are observed. The infiltrate likewise surrounds
`sebaceous ducts and glands. The veins are thickened and
`grossly dilated. Elastosis is more advanced. In stage III there
`is diffuse expansion of the connective tissue, accompanied
`by hyperplasia of sebaceous follicles with long, distorted
`follicular canals, and
`large,
`irregular sebaceous acini.
`Epithelialized tunnels undermine the hyperplastic tissue
`and are filled with inflammatory debris. The elastotic
`changes are prominent, often evident as amorphaus masses
`of degenerated elastic tissue. D. jolliculorum mites are often
`found within the follicular infundibula and sebaceous ducts.
`They are merely commensals. This is different from true
`Demodex folliculitis ( demodicosis). Epithelioid granulomas of
`the non-caseating type with multiple foreign-body multi-
`nucleated cells are the histopathological equivalent of lupoid
`rosacea. Abscesses with pseudoepitheliomatous hyperplasia,
`lakes of granulocytes are
`widespread necrosis, and
`characteristic of rosacea fulminans.
`
`DIFFERENTIAL DIAGNOSIS
`Acne vulaaris is distinguishable from rosacea by its lack of
`vascular component. T elangiectases and erythema are
`usually absent. Comedones and cysts are not seen in
`rosacea. Acne lesions may resolve into small fibrotic
`nodules and scars (which are absent in rosacea). Perioral
`is a symmetrical eruption consisting of tiny
`dermatitis
`vesicles and micropapules on an erythematous background.
`These lesions may appear in crops, sometimes with scaling.
`Occasionally, perioral dermatitis is accompanied by a
`similar eruption in the glabellar, malar, and periorbital
`
`regions. Rebound after discontinuation of potent topical
`corticosteroids seems
`to play a role
`in many cases.
`Seborrhoeic dermatitis, which may coexist with rosacea, is
`polymorphous, as are the other eczemas. Thus scaling and
`even mild vesiculation may occur. In cantrast to rosacea,
`seborrhoeic dermatitis involves the paranasal area,
`the
`nasalabial grooves, the retroauricular region, and several
`areas beyond the face. Photodermatitis can be toxic or allergic
`the polymorphic feature of
`in nature. When allergic,
`eczema occurs and the eruption is usually present in
`toxic,
`the
`extrafacial photo-distribution areas. When
`eruption resembles a sunbum. Polymorphaus liaht eruption
`is a photosensitive eruption usually appearing in spring or
`early summ er, consisting of erythematous papules or
`eczematous plaques. Unlike in rosacea, itching is common
`after intensive sun exposure and before the eruption. The
`diagnosis is confirmed by phototesting. Chronic discoid lupus
`ezythematosus has pigmentary changes, atrophy, and scarring
`which rule out rosacea. When lupus erythematosus is
`systemic and there is a symmetrical erythema especially
`intense over both malar areas, the distinction may be
`difficult. This difficulty is compounded by a positive lupus
`band test in the facial skin of some patients with rosacea36.
`A thorough evaluation for other evidence of systemic lupus
`erythematosus is indicated in these cases. Haber's syndrome is
`a rare familial rosacea-like genodermatosis with persistent
`facial erythema, telangiectases, follicular and verrucous
`papules, and atrophic pitted scars37. The patientsoften have
`dry facial skin and xerosis of their body. Finally, in patients
`with the sudden onset of severe flushing, systemic fiushinB
`disorders, such as carcinoid syndrome,_ must be considered.
`The 24-h urinary excretion of 5-hydr~xy.jndoleacetic acid is
`normal in rosacea38.
`
`TREATMENT
`Rosacea
`is
`treatable but seldom curable. Treatment
`schedules are determined by the stage and severity of the
`disease.
`
`Topical
`All sources of local irritation, such as soaps, alcoholic
`cleansers, tinctures and astringents, abrasives and peeling
`agents must be avoided. Only very mild soaps or properly
`diluted detergents are advised. Protection agairrst surrlight is
`important: sunscreens with a protecting factor (SPF) of 15
`or higher are always recommended, preferably of the broad
`spectrum UV-A plus UV-B type. For some it may be hard
`to find a sunscreen which is tolerated without buming or
`irritation. Fernale patients can be encouraged to hide
`telangiectases with cosmetic bases having a green tint.
`The antibiotics used in acne are sometimes effective.
`Tetracyclines, clindamycin, and erythromycin, usually in
`
`147
`
`Exh. 1034
`
`

`
`JOURNAL OF THE ROYAL SOCIETY OF MEDICINE Volume 90 March 199
`
`concentrations from 0.5% or 2.0%, are commercially
`available. In one study, twice daily application of 1%
`clindamycin phosphate lotion in an aqueous base was
`equivalent in efficacy to 250 mg oral tetracycline twice a
`day, without important side-effects over a 12-week triaP9.
`The mechanism of antibiotics may be anti-inflammatory
`rather than antibacterial. Tetracyclines and erythromycin
`reduce leucocyte migration and phagocytosis40.
`Metronidazole is a synthetic nitroimidazole-derivative
`antibacterial and antiprotozoal agent, available in the USA
`and the UKas a 0.75% aqueous gel (MetroGel). In clinical
`studies metronidazole 0. 7 5% topical gel or 1. 0% cream
`improved inflammatory lesions in 68-96% of patients41 .
`The gel is applied twice daily and is most effective in
`papular and pustular rosacea. It does not alter erythema,
`telangiectases, or flushing. When the drug is withdrawn,
`symptoms commonly recur. Where a registered prepara-
`tion is not available we suggest the following prescription:
`metronidazole 2.0; Eucerin lotion ad 100.0. This 2%
`metronidazole lotion is applied once or twice daily as long
`as necessary. The principal adverse effects of topically
`applied metronidazole are local reactions such as burning
`and stinging.
`treatment of
`increasingly used for
`Imidazoles are
`rosacea42. In our experience, not substantiated by clinical
`trials, ketoconazole cream (Nizoral cream) is the best
`choice, applied once or twice daily. The mechanisJ;n may be
`anti-inflammatory or
`immunosuppressive
`rather
`than
`bactericidal. Imidazoles seem to have low 'toxicity and are
`well tolerated by patients with sensitive skin.
`Old-time remedies such as drying lotions should not be
`forgotten43 . A very thin application at night is recom-
`mended. One can use commercial precipitated sulphur
`lotions. We prescribe: hydragyrum sulphur rubr 0.5;
`sulphur praecipitati 2. 0; Lotio zinci ad 1 00.0.
`T opical retinoids provide another option. The acneiform
`component responds to tretinoin44. Isotretinoin is worth a
`trial. There is preliminary evidence that 0. 2% isotretinoin
`in a bland cream is helpful45 ; it is less irritating than
`tretinoin and suppresses inflammatory lesions in stage II and
`III.
`
`In a double-blind randomized half-face comparison
`between 20% azelaic acid cream preparation and
`its
`identical-appearing vehicle as placebo, azelaic acid was
`effective against papules, pustules, and erythema
`in
`rosacea46. The only adverse effect over 9 weeks was minor
`skin irritation. Probably the anti-inflammatory activity of
`azelaic acid accounts for a substantial proportion of the
`therapeutic effect.
`that Demodex
`As stated above, we do not think
`jolliculorum mites have a causal role in rosacea. However,
`massive infestations may aggravate the condition. A check
`for mites is best done with the skin-surface biopsy technique
`
`(place a drop of cyanoacrylate on a glass slide, cover with
`immersion oil, and examine with the 10 X or 20 X objec-
`tive in the light microscope)47. The mites are satisfactorily
`controlled with lindane (y-hexachlorocyclohexane), crota-
`miton, or benzyl benzoate once daily for two to five days.
`T opical corticosteroids should not be used, except in
`rosacea fulminans30·31 . In these patients short courses of
`high-potency topical corticosteroids are a reasonable option
`to reduce the inflammation.
`
`Systemic
`to oral antibiotics.
`Rosacea generally responds well
`is often effective, but tetracyclines are
`Erythromycin
`preferable48. Tetracycline-HCl, oxytetracycline, doxycy-
`cline, and minocycline are usually effective in controlling
`papulopustular rosacea and even reducing erythema. One
`should start with large doses-1 . 0-1.5 g tetracycline-H Cl
`or oxytetracycline per day. 50 mg of minocycline or
`doxycycline
`twice daily can be given. As soon as
`papulopustules are fully controlled (usually after two to
`three weeks) doses of 250-500 mg tetracycline-HCl or
`oxytetracycline, or 50 mg minocycline or doxycycline, per
`day are generally sufficient. Rosacea patients often titrate
`to disease activity and should be
`doses according
`encouraged
`to do so. Some get by with 250 mg
`tetracycline-HCl on altemate days. Oral tetracyclines are
`effective in ophthalmic rosacea49. Antibiotic use in rosacea
`is often not sufficiently monitored. The disease has its ups
`and downs. Too often patients are on a fixed oral dose for
`many years when topical dr?-gs might be sufficient.
`(13-cis-reti~oi~ acid)
`is
`exceptionally
`Isotretinoin
`effective though far more risky than tetracyclines23,50-52.
`It may be appropriate for all forms of severe or therapy-
`resistant rosacea, especially the variants unresponsive to
`antibiotics, e.g. lupoid rosacea, stage III rosacea, Gram-
`negative rosacea, rosacea conglobata, and rosacea fulmi-
`nans. It is particularly helpful in patients who have oily,
`wide-pored skin and multiple sebaceous gland hyperplasias.
`In addition, all forms of phyma are indications. The dose
`required for control of rosacea varies. Three treatment
`schedules will be outlined.here. The dose of isotretinoin is
`0. 5-l. 0 mg/kg per day as used in acne. Side-effects on the
`eyes make
`this dose
`intolerable for many patients.
`Ophthalmie rosacea may get worse and likewise dry eye
`and blepharitis. Patients may become unable to use contact
`lenses. The high dose is used only in rosacea fulminans, or
`preoperatively for a couple of months to shrink rhinophyma
`before surgical reduction. Low-dose isotretinoin is much
`better and safer. 0.1-0.2 mg/kg per day is usually effective
`in severe rosacea, though clearing may take Ionger.
`Minidose isotretinom is 2. 5 mg or 5. 0 mg daily (not
`adjusted to bodyweight). This dose is surprisingly helpful in
`
`148
`
`Exh. 1034
`
`

`
`JOURNAL OF THE ROYAL SOCIETY OF MEDICINE Volume 90 March 199
`
`many forms of the clisease, especially stage III rosacea,
`lupoid rosacea, and persistent oedema in rosacea. Side-
`effects on the eyes are negligible. Duration of therapy is
`Ionger than with the other doses, about 6 months. The
`cumulative dose, however, is low. The usual precautions
`apply. Isotretinoin is a teratogen and is contraindicated in
`women of childbearing age unless they meet all
`the
`requirements on the package Iabel. Aminotransferases,
`cholesterol, and triglycerides must be measured before
`thereafter. With
`therapy and monthly or bimonthly
`minidose isotretinoin no laboratory abnormalities have
`been observed.
`In an uncontrolled study of 13 J apanese male rosacea
`patients53 good results were reported with spironolactone.
`50 mg daily over four weeks seemed to improve itching and
`erythema, perhaps via inhibition of epidermal cytochrome P-
`450. Further stuclies are necessary
`to confirm
`this.
`Clonidine, in a limited trial, reduced facial flushing54, but
`doses which do not decrease blood pressure have little or no
`effect55 . Metronidazole is licensed for the treatment of
`infections
`caused by Trichomonas
`vaginalis, Entamoeba
`histolytica, and Giardia intestinalis. The usual dose is 500 mg
`twice daily for six days. Oral metronidazole is effective in all
`types of rosacea, including Stages II and III56. However' 20
`to 60 days may be needed to achieve control with a daily
`dose of 500 mg. It should be regarded as a second-line drug.
`Rosacea fulminans requires special care30,31 . Treatment
`starts with oral corticosteroids (e.g., prednisolone l.Omg/
`kg per day), for one week to cool down the fire~ Then
`isotretinoin is added, at around 0.2-0.5 mg/kg, rarely 1.0
`mg/kg, per day, with a slow tapering of the corticosteroid
`over the next two to three weeks. Isotretinoin is continued
`until all inflammatory lesions have clisappeared. This may
`require three to four months. Draining abscess.es should not
`be incised. Warm compresses can be applied, tagether with
`a potent corticosteroid cream (for the first 2 weeks only).
`
`Miscellaneous
`Facial massage has long been recommended. This is the so-
`called Sobye's massage57. Controlled studies are lacking.
`Twice daily gentle circular massage is given for several
`minutes to nose, cheeks, and forehead.
`There is no specific rosacea diet. Dietary limitations
`relate only to factors which provoke erythema, flushing and
`blushing such as alcoholic beverages, hot drinks, and spicy
`food. The patients themselves may find out which dietary
`items are troublesome.
`Obliteration of ectatic vessels, particularly on the nose,
`can be achieved by intravascualr insertion of a fine
`diathermy needle or by argon or

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket